Identification and Validation of a Gene Signature for Lower-Grade Gliomas Based on Pyroptosis-Related Genes to Predict Survival and Response to Immune Checkpoint Inhibitors

Figure 6

The relationship between tumor-infiltrating immune cells and PRS gene signature. (a) The proportion of tumor-infiltrating immune cells between the low-risk group and high-risk group in TCGA. (b) The proportion of tumor-infiltrating immune cells between the low-risk group and high-risk group in CGGA. Data in (a-b) were analyzed by Wilcoxon test; ns, no significance; ^∗p < 0.05, ^∗∗p < 0.01, and ^∗∗∗p < 0.001.

(a)

(b)